Related Experiment Video
Updated: Jul 13, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation
E Messas1, J L Guerrero, M D Handschumacher
1Cardiac Ultrasound Laboratory and Surgical Cardiovascular Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Background:
Mitral regurgitation (MR) conveys adverse prognosis in ischemic heart disease. Because such MR is related to increased leaflet tethering by displaced attachments to the papillary muscles (PMs), it is incompletely treated by annular reduction. We therefore addressed the hypothesis that such MR can be reduced by cutting a limited number of critically positioned chordae to the leaflet base that most restrict closure but are not required to prevent prolapse. This was tested in 8 mitral valves: a porcine in vitro pilot with PM displacement and 7 sheep with acute inferobasal infarcts studied in vivo with three-dimensional (3D) echo to quantify MR in relation to 3D valve geometry.
Methods And Results:
In all 8 valves, PM displacement restricted leaflet closure, with anterior leaflet angulation at the basal chord insertion, and mild-to-moderate MR. Cutting the 2 central basal chordae reversed this without prolapse. In vivo, MR increased from 0.8+/-0.2 to 7.1+/-0.5 mL/beat after infarction and then decreased to 0.9+/-0.1 mL/beat with chordal cutting (P<0.0001); this paralleled changes in the 3D leaflet area required to cover the orifice as dictated by chordal tethering (r(2)=0.76).
Conclusions:
Cutting a minimum number of basal chordae can improve coaptation and reduce ischemic MR. Such an approach also suggests the potential for future minimally invasive implementation.
Insights
Cutting specific basal chordae in mitral valves effectively reduces ischemic mitral regurgitation by improving leaflet closure without causing prolapse. This minimally invasive approach shows promise for treating this heart condition.
Area of Science:
- Cardiovascular Surgery
- Cardiac Mechanics
- Interventional Cardiology
Background:
- Ischemic mitral regurgitation (MR) is linked to adverse prognosis in heart disease.
- Leaflet tethering due to papillary muscle displacement causes MR, which is not fully addressed by annular reduction.
- The hypothesis tested was that selective chordae cutting could reduce MR by releasing leaflet restriction.
Purpose of the Study:
- To investigate the efficacy of cutting specific basal chordae in reducing ischemic mitral regurgitation.
- To assess the impact of chordal cutting on mitral valve geometry and function.
- To explore a potential minimally invasive treatment for ischemic MR.
Main Methods:
- Experiments were conducted on 8 mitral valves, including a porcine in vitro model and 7 sheep with induced myocardial infarction.
- Three-dimensional (3D) echocardiography was used to quantify MR and analyze 3D valve geometry in vivo.
- Selective cutting of basal chordae was performed to release leaflet tethering.
Main Results:
- Papillary muscle displacement caused leaflet restriction and mild-to-moderate MR in all tested valves.
- Cutting the two central basal chordae effectively reduced MR without inducing prolapse.
- In vivo, MR significantly decreased from 7.1±0.5 mL/beat post-infarction to 0.9±0.1 mL/beat after chordal cutting (P<0.0001).
Conclusions:
- A minimal chordae cutting strategy can improve mitral valve coaptation and reduce ischemic MR.
- This approach offers a potential method for future minimally invasive interventions for ischemic MR.
Related Concept Videos
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

